Boston Scientific's device shows promise in restoring normal heart rhythms

09/3/2013 | MassDevice.com (Boston)

A study of 330 patients implanted with Boston Scientific's subcutaneous implantable cardiac defibrillator found that the device successfully restored normal heart rhythms in 38 patients who suffered heart irregularity during an 11-month evaluation period. The device also reversed heart rhythm irregularity 100% of the time, surpassing the FDA target of an 88% response rate, when researchers tested it by causing an abnormal heart rhythm, according to the study in the journal Circulation.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN